The move will create the largest operator of outpatient surgery centers in the U.S.
The health insurer will sell its occupational health care provider unit since it turned out not to be a good fit.
AbbVie could reap more than $7 billion in annual sales from the promising new cancer drug Imbruvica.
Johnson & Johnson completes its exit from the cardiovascular stent business in this deal by year's end.
The deal will take Valeant into a growing, $5 billion annual market for drugs treating stomach disorders.
Deal to purchase NPS Pharmaceuticals will strengthen position in field of medicines for rare diseases.
Chinese prosecutors have formally filed charges against couple linked to bribery claims.
The Basel-based drugmaker is looking to bolster its offering of breast cancer drugs with the purchase.
Deal will allow the U.S. medical device maker to reduce its overall global tax burden.
Drugs giant is to have its "commercial practices" investigated by the Serious Fraud Office.
Copyright © 2015. All rights reserved.